Retrieve available abstracts of 28 articles: HTML format
Single Articles
April 2025
WIBOWO DP, Chalid MT, Rasyak MR, El Khobar KE, et al Characteristics of hepatitis B virus surface protein and occult hepatitis B
infection in infants with immunoprophylaxis failure from Indonesia.
Vaccine. 2025;56:127130. PubMedAbstract available
WANG F, Zheng J, Qiu F, Yang Y, et al Long-term effectiveness of vaccination for prevention of hepatitis B virus
mother-to-child transmission in Yunnan, China.
Vaccine. 2025;54:127128. PubMedAbstract available
March 2025
OKOLI GN, Grossman Moon A, Soos AE, Neilson CJ, et al Hepatitis B vaccination initiation and vaccination series completion: An in-depth
systematic evidence review, with meta-analysis of associations with individual
socioeconomic and health-related factors.
Vaccine. 2025;55:127051. PubMedAbstract available
VYSOTSKAYA V, Gassowski M, Kasper A, Gasich E, et al Hepatitis B serosurvey to validate the achievement of regional hepatitis B
control targets in Belarus.
Vaccine. 2025;55:127058. PubMedAbstract available
KANG M, Marks KM, Cox AL, Sherman KE, et al An efficient vaccine clinical trial: ACTG A5379 hepatitis B vaccine trial in
persons with HIV.
Vaccine. 2025;55:127028. PubMedAbstract available
GHARPURE R, Vegvari C, Abdissa A, Alimi Y, et al Meeting report: CEPI workshop on Rift Valley fever epidemiology and modeling to
inform human vaccine development, Nairobi, 4-5 June 2024.
Vaccine. 2025;54:126860. PubMedAbstract available
January 2025
JIANG Y, Luo Y, Xiao X, Li X, et al Global, regional, and national burdens of vaccine-preventable infectious diseases
with high incidence among middle-aged and older adults aged 55-89 years from 1990
to 2021: Results from the global burden of disease study 2021.
Vaccine. 2025;49:126786. PubMedAbstract available
KHETSURIANI N, Tursunova D, Kasimova R, Sharapov S, et al Prevalence of chronic hepatitis B virus infection among children in Uzbekistan:
Impact of vaccination.
Vaccine. 2025;48:126743. PubMedAbstract available
CHIU CY, Sampathkumar P, Brumble LM, Vikram HR, et al Optimizing hepatitis B virus seroprotection in thoracic organ transplantation:
The role of HepB-CpG (Heplisav-B) vaccination schedule.
Vaccine. 2025;47:126705. PubMedAbstract available
SEO H, Kim BJ, Oh J, Jung S, et al Protection against tuberculosis by vaccination of secreted chorismate mutase
(Rv1885c) combined with a hepatitis B virus (HBV)-derived peptide, Poly6, and
alum adjuvants.
Vaccine. 2025;47:126710. PubMedAbstract available
SU Q, Qiu F, Gao Z, Zhao Y, et al Long-term efficacy and anamnestic response of hepatitis B vaccine derived from
Chinese hamster ovary cell after 18-20 years.
Vaccine. 2025;47:126655. PubMedAbstract available
November 2024
GRIGAS J, Spancerniene U, Simanavicius M, Pautienius A, et al Adaptive immune response to a wild boar-derived recombinant hepatitis e virus
capsid protein challenge in pigs.
Vaccine. 2024 Nov 30:126561. doi: 10.1016/j.vaccine.2024.126561. PubMedAbstract available
BERTHOUD TK, Ahmed T, Nadia W, Petrov I, et al A three antigen hepatitis B vaccine induces T cells to Pres1 and Pres2 which
correlate with anti HBs antibody titers: An investigation into the immunological
mechanisms contributing to high anti-HBs titers.
Vaccine. 2024;43. PubMedAbstract available
October 2024
NG AJJ, Teo DCH, Dorajoo SR, Yap AJY, et al Acute autoimmune hepatitis following COVID-19 mRNA vaccination: A
population-based study using electronic health records in Singapore.
Vaccine. 2024;42:126462. PubMedAbstract available
AREFAINE M, Johannessen A, Teklehaymanot T, Mihret A, et al A prospective, multicenter study of hepatitis B birth-dose vaccine with or
without hepatitis B immunoglobulin in preventing mother-to-child transmission of
hepatitis B virus in Ethiopia.
Vaccine. 2024;42:126461. PubMedAbstract available
KANG S, Chung E, Hong C, Aziz AB, et al Raising the case of hepatitis E: Report from the 2nd international HEV symposium.
Vaccine. 2024;42:126398. PubMedAbstract available
September 2024
HOU X, Li N, Zhang H, Liu W, et al Hepatitis B virus infection and vaccination among people who use drugs in Xi'an,
China.
Vaccine. 2024;42:126259. PubMedAbstract available
August 2024
DONG R, Luo Z, Shao J, Xue H, et al Understanding hepatitis E vaccination intention among women of childbearing-age:
A theory-based cross-sectional study.
Vaccine. 2024;42:126258. PubMedAbstract available
KANU FA, Freeland C, Nwokoro UU, Mohammed Y, et al Evaluation of interventions to improve timely hepatitis B birth dose vaccination
among infants and maternal tetanus vaccination among pregnant women in Nigeria.
Vaccine. 2024;42:126222. PubMedAbstract available
July 2024
BESBASSI H, Elias G, Meysman P, Jansens H, et al Modeling antigen-specific T cell dynamics following Hepatitis B Vaccination
indicates differences between conventional and regulatory T cell dynamics.
Vaccine. 2024;42:126148. PubMedAbstract available
MESHRAM R, Kolte B, Gacche R Reverse vaccinology approach for identification of epitopes from E1 protein as
peptide vaccine against HCV: A proof of concept.
Vaccine. 2024 Jul 5:S0264-410X(24)00747-3. doi: 10.1016/j.vaccine.2024. PubMedAbstract available
KOUTSOUMPLI G, Stasiukonyte N, Hoogeboom BN, Daemen T, et al An in vitro CD8 T-cell priming assay enables epitope selection for hepatitis C
virus vaccines.
Vaccine. 2024 Jul 3:S0264-410X(24)00659-5. doi: 10.1016/j.vaccine.2024. PubMedAbstract available
February 2024
KOCHHAR S, Assis DN, Mack C, Izurieta HS, et al Autoimmune hepatitis: Brighton Collaboration case definition and guidelines for
data collection, analysis, and presentation of immunisation safety data.
Vaccine. 2024 Feb 16:S0264-410X(24)00021-5. doi: 10.1016/j.vaccine.2024. PubMedAbstract available
January 2024
SANTORO PE, Paladini A, Borrelli I, Amantea C, et al Vaccine-preventable diseases: Immune response in a large population of healthcare
students.
Vaccine. 2024 Jan 20:S0264-410X(24)00049-5. doi: 10.1016/j.vaccine.2024. PubMedAbstract available
December 2023
DIONNE M, Sauvageau C, Kiely M, Dahhou M, et al School-based vaccination program against HPV and Hepatitis B: A longitudinal
analysis of vaccine coverage between 2015 and 2021 in Quebec.
Vaccine. 2023 Dec 2:S0264-410X(23)01419-6. doi: 10.1016/j.vaccine.2023. PubMedAbstract available
September 2023
SANADA T, Oda Y, Ohashi C, Isotani K, et al Hybrid large hepatitis B surface protein composed of two viral genotypes C and D
induces strongly cross-neutralizing antibodies.
Vaccine. 2023 Sep 20:S0264-410X(23)01096-4. doi: 10.1016/j.vaccine.2023. PubMedAbstract available
BIRNBAUM JA, Guttman D, Parulekar M, Omarufilo F, et al Eliminating hepatitis B vaccination disparities for West African immigrants.
Vaccine. 2023 Sep 3:S0264-410X(23)01012-5. doi: 10.1016/j.vaccine.2023. PubMedAbstract available
SUSARLA SK, Gupta M, Uttam KG, Palkar S, et al Immunogenicity and safety of Havisure(TM) vaccine developed by Human Biologicals
Institute in healthy subjects of 12 months to 49 years of age: A phase II/III,
randomized, single blind, non-inferiority study.
Vaccine. 2023 Sep 1:S0264-410X(23)01050-2. doi: 10.1016/j.vaccine.2023. PubMedAbstract available